Jae Hong Park, MD: Improving Outcomes, Minimizing Toxicity With CAR T-Cell Therapy in B-Cell ALL
0 意见
• 07/05/23
0
0
嵌入
Dr. Park reviews two studies presented at, identifying characteristics that can improve durability of outcome, without increasing toxicity, in patients with B-cell acute lymphocytic leukemia.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论